Cu催化下C–N键的形成:N-芳基取代的噻吩并[2,3 - d ]嘧啶-4(3 H)-酮类抗分支酸突变的合成及体外评价
摘要:
设计并合成了一系列新型的N-芳基取代的噻吩并[2,3 - d ]嘧啶-4(3 H)-酮类化合物作为分支酸突变酶的潜在抑制剂。此类化合物的合成是通过硫代[2,3- d ]嘧啶-4(3 H)-一和芳基硼酸。该反应可以在敞口烧瓶中进行,因为发现该转化对空气或大气水分的存在不敏感。使用这种方法可以制备多种化合物,并使用代表性化合物进行单晶X射线衍射研究。介绍了一些合成的化合物的体外药理数据,以及使用活性分子进行的剂量反应研究。在计算机上也显示了这些分子与分支酸突变酶的相互作用。
The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
C–N bond formation under Cu-catalysis: Synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase
A series of novel N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones were designed and synthesized as potential inhibitors of chorismate mutase. Synthesis of this class of compounds was carried out by using Cu-mediated C–N bond forming reaction between thieno[2,3-d]pyrimidin-4(3H)-ones and aryl boronic acids. The reaction can be performed in an open flask as the conversion was found to be not sensitive
设计并合成了一系列新型的N-芳基取代的噻吩并[2,3 - d ]嘧啶-4(3 H)-酮类化合物作为分支酸突变酶的潜在抑制剂。此类化合物的合成是通过硫代[2,3- d ]嘧啶-4(3 H)-一和芳基硼酸。该反应可以在敞口烧瓶中进行,因为发现该转化对空气或大气水分的存在不敏感。使用这种方法可以制备多种化合物,并使用代表性化合物进行单晶X射线衍射研究。介绍了一些合成的化合物的体外药理数据,以及使用活性分子进行的剂量反应研究。在计算机上也显示了这些分子与分支酸突变酶的相互作用。